Although the resazurin assay is known to respond to mitochondrial metabolism, and this in turn is correlated with cellular viability [28, 29], it was of interest to assess whether these extended P-gp inhibitor treatments after short chemotherapy exposures actually decreased cancer cell survival. Here, PGP is linked to cancer.